Monoclonal Antibodies for COVID-19 Treatment: Is It an Option in Indonesia?
More than three years after Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV2), was declared pandemic by World Health Organization, report of COVID-19 hospitalization and death have been decreasing. Even though COVID-1...
Saved in:
Main Author: | Alvina Widhani (Author) |
---|---|
Format: | Book |
Published: |
Interna Publishing,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An update to monoclonal antibody as therapeutic option against COVID-19
by: Paroma Deb, et al.
Published: (2021) -
Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment
by: Catalina Ayón, et al.
Published: (2022) -
Monoclonal Antibodies for Treatment of COVID-19: An Updated Review of Current Evidence
by: Saurabh Nimesh, et al.
Published: (2024) -
Monoclonal antibody therapy for COVID-19 during pregnancy
by: Diana I. Abdulganieva, et al.
Published: (2023) -
Monoclonal Antibodies
Published: (2021)